NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
26/03/2024
Voltar para busca
Dado oficial do USPTO
SOLCO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
22
Atualização mais recente
26/03/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
17/11/2022
Data de registro
26/03/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/03/2024
Última transação
26/03/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Primeiro uso
03/06/2009
Primeiro uso no comércio
03/06/2009
Código do desenho
4
Tipo de titular
03
Localização do titular
Somerset, NJ
Examinador
KENEALY, NATALIE
Unidade examinadora
L40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Prinston Pharmaceutical Inc.
Representantes
Thomas L. Holt Perkins Coie LLP
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Analgesic and muscle relaxant pharmaceutical preparations; antibacterial pharmaceuticals; antimicrobial preservatives for cosmetics and pharmaceuticals; pharmaceutical astringents being astringents for medical purposes; balms for pharmaceutical purposes; cream of tartar for pharmaceutical purposes; creosote for pharmaceutical purposes; dermatological pharmaceutical products; digestives for pharmaceutical purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; ferments for pharmaceutical purposes; inhaled pharmaceutical preparations for the treatment of respiratory disease; injectable pharmaceuticals for treatment of anaphylactic reactions; intravenous fluids used for rehydrationnutrition and the delivery of pharmaceutical preparations; iodine for pharmaceutical purposes; liquorice for pharmaceutical purposes; menthol for pharmaceutical purposes; pharmaceutical antitussive-cold preparations; pharmaceutical anti-allergic preparations and substances; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical preparationsanticoagulants; pharmaceutical preparationsappetite suppressants; pharmaceutical preparation for the treatment of gout; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparationsa drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for use in urology; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparationsa topical preparation for the treatment of ocular disorders prescribed by ophthalmologistseye surgeonsoptometrists; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparationsinjectable contraceptives; pharmaceutical preparations for treating allergies; pharmaceutical preparations for treating hypertension; pharmaceutical products for treating respiratory disease and asthma; pharmaceutical products for the treatment of joint disease; plant extracts for medicalveterinary and pharmaceutical purposes; potassium preparations for pharmaceutical purposes; pharmaceutical preparations and substances for weight loss; vitamin and mineral supplements for use as ingredients in the food and pharmaceutical industry; drug delivery agents in the form of coatings for pills for facilitating the delivery of a wide range of pharmaceuticals; biological preparations for the treatment of cancer and autoimmune deficiencies and disorders; pharmaceuticalveterinary and sanitary preparationsconjugates of organic and inorganic chemicals with polypeptidesproteinsartificial polypeptidesartificial proteins produced by genetic engineering and for the treatment of viral and infectious diseasesimmune system disorderscancerdiabetescardiovascular diseasescentral nervous system disorders and diseases; anti-diabetic pharmaceuticals; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesfor the treatment of bacteria-based diseasesfor the treatment of diabetesanti-infective preparationsantiviral preparationsantibioticsantifungal preparations and vaccines; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; prescription and non-prescription medicinespillstabletscapsulescapletsliquid dropssachets and pharmaceutical preparations for the treatment of cardiovascular disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; pharmaceutical preparations for treating skin disorders; pharmaceutical products for the treatment of viral and infectious diseasesfor the treatment of cancer
Publicações
Histórico de despachos e eventos da marca no USPTO.
22 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
26/03/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/01/2024
PUBO
PUBLISHED FOR OPPOSITION
09/01/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20/12/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/12/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/12/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/12/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/12/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
30/11/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
30/11/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
30/11/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
30/11/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
30/11/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/09/2023
GNRT
NON-FINAL ACTION E-MAILED
07/09/2023
CNRT
NON-FINAL ACTION WRITTEN
07/09/2023
DOCK
ASSIGNED TO EXAMINER
30/08/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/12/2022
NWAP
NEW APPLICATION ENTERED
21/11/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SOLCO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.